المؤلفون: Alessio Cortellini, Gino M Dettorre, Urania Dafni, Juan Aguilar-Company, Luis Castelo-Branco, Matteo Lambertini, Spyridon Gennatas, Vasileios Angelis, Ailsa Sita-Lumsden, Jacobo Rogado, Paolo Pedrazzoli, David Viñal, Aleix Prat, Maura Rossi, Rossana Berardi, Teresa Alonso-Gordoa, Salvatore Grisanti, Georgia Dimopoulou, Paola Queirolo, Sylvain Pradervand, Alexia Bertuzzi, Mark Bower, Dirk Arnold, Ramon Salazar, Marco Tucci, Kevin J Harrington, Francesca Mazzoni, Uma Mukherjee, Zoi Tsourti, Olivier Michielin, Fanny Pommeret, Joan Brunet, Bruno Vincenzi, Giuseppe Tonini, Andrea Patriarca, Federica Biello, Marco Krengli, Josep Tabernero, George Pentheroudakis, Alessandra Gennari, Solange Peters, Emanuela Romano, David J Pinato

المساهمون: Institut Català de la Salut, [Cortellini A] Department of Surgery & Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK. Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy. [Dettorre GM] Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. [Dafni U] Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece. [Aguilar-Company J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Castelo-Branco L] Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland. NOVA National School of Publich Health, NOVA University, Lisbon, Portugal. [Lambertini M] Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy. Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Vall d'Hebron Barcelona Hospital Campus, Wellcome Trust

المصدر: Scientia

مصطلحات موضوعية: Cytotoxicity, Immunologic, Cancer Research, Immunology, Immunoteràpia, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Immunotheraphy, Vacunes, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Medical Oncology, COVID-19 (Malaltia), Cell-mediated cytotoxicity, neoplasias [ENFERMEDADES], Immunitat cel·lular, Immunogenicity, Vaccine, COVID-19 Testing, Neoplasms, Immunogenetics, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Immunology and Allergy, Humans, Immunologia, Vacunació, Registries, Immune Checkpoint Inhibitors, Pharmacology, Vaccines, Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], SARS-CoV-2, Càncer - Tractament, terapéutica::terapia biológica::inmunomodulación::inmunoterapia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Vaccination, COVID-19, Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Cancer patients, Cellular immunity, Citotoxicitat per mediació cel·lular, Neoplasms [DISEASES], Malalts de càncer, Oncology, Molecular Medicine, Immunotherapy, Immunogenètica

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0e4d9c56f300f2dc48f4bec216bb4a
https://pubmed.ncbi.nlm.nih.gov/36450384

المؤلفون: Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, Nikolaos Diamantis, John Chester, Charlotte Moss, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, Joan Brunet, Eleanor Jones, Ricard Mesia, Amanda Jackson, Uma Mukherjee, Ailsa Sita-Lumsden, Elia Seguí, Diego Ottaviani, Anna Carbó, Sarah Benafif, Rachel Würstlein, Carme Carmona, Neha Chopra, Claudia Andrea Cruz, Judith Swallow, Nadia Saoudi, Eudald Felip, Myria Galazi, Isabel Garcia-Fructuoso, Alvin J. X. Lee, Thomas Newsom-Davis, Yien Ning Sophia Wong, Anna Sureda, Clara Maluquer, Isabel Ruiz-Camps, Alba Cabirta, Aleix Prat, Angela Loizidou, Alessandra Gennari, Daniela Ferrante, Josep Tabernero, Beth Russell, Mieke Van Hemelrijck, Saoirse Dolly, Nicholas J Hulbert-Williams, David J Pinato, Meritxell Mollà, Roxana Reyes, Javier Marco-Hernández, Riccardo Bruna, Federica Biello, Andrea Patriarca, Alberto Zambelli, Carlo Tondini, Vittoria Fotia, Lorenzo Chiudinelli, Michela Franchi, Daniele Generali, Salvatore Grisanti, Valeria Tovazzi, Alexia Bertuzzi, Andrea Marrari, Pavetha Seeva, Palma Dileo, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Marta Betti, Salvatore Provenzano, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Raquel Liñan, Ariadna Roqué, Oriol Mirallas, David García-Illescas, Lorenza Scotti, Alessia Dalla Pria, Francesca D’Avanzo, Maria Martinez, Joanne S Evans, Rachel Sharkey, Lorenza Rimassa, Armando Santoro, Gianluca Gaidano, Macarena Izuzquiza

المساهمون: Institut Català de la Salut, [Soosaipillai G] Cancer Division, University College London Hospitals, London, UK. [Wu A] Cancer Division, University College London Hospitals, London, UK UCL Cancer Institute, Fitzrovia, London, UK. [Dettorre GM] Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. [Diamantis N] Medical Oncology, Barts Health NHS Trust, London, UK. [Chester J] Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK. Medical Oncology, Velindre Cancer Centre, Cardiff, UK. [Moss C] Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK. [Aguilar-Company J] Servei d’Oncologia Mèdica, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Saoudi N, Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ruiz-Camps I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Cabirta A] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Wellcome Trust, Cancer Treatment & Research Trust, Imperial College Healthcare NHS Trust- BRC Funding

المصدر: Scientia
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: medicine.medical_specialty, 2019-20 coronavirus outbreak, Palliative care, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Palliative treatment, COVID-19 (Malaltia), end-of-life (EOL), neoplasias [ENFERMEDADES], 03 medical and health sciences, 0302 clinical medicine, Therapeutics::Patient Care::Terminal Care::Hospice Care [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], 030502 gerontology, medicine, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], cancer, Symptom control, Intensive care medicine, Specialist palliative care, RC254-282, Otros calificadores::/terapia [Otros calificadores], Original Research, end-of life care (EOLC), business.industry, Càncer - Tractament, Perspective (graphical), speciality palliative care team (SPCT), Cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, COVID-19, Cancer patients, Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Other subheadings::/therapy [Other subheadings], medicine.disease, 3. Good health, Malalts de càncer, Neoplasms [DISEASES], Oncology, 030220 oncology & carcinogenesis, Tractament pal·liatiu, terapéutica::asistencia al paciente::asistencia en fase terminal::cuidados paliativos al final de la vida [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], 0305 other medical science, business, End-of-life care

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4681411733e1cedea4d298f7fafda922
https://hdl.handle.net/11351/7430

المؤلفون: Dettorre, Gino M., Dolly, Saoirse, Loizidou, Angela, Chester, John, Jackson, Amanda, Mukherjee, Uma, Zambelli, Alberto, Aguilar Company, Juan, Bower, Mark, Sng, Christopher C. T., Salazar Soler, Ramón, Bertuzzi, Alexia, Brunet, Joan, Mesia, Ricard, Sita-Lumsden, Ailsa, Seguí, Elia, Biello, Federica, Generali, Daniele, Grisanti, Salvatore, Seeva, Pavetha, Rizzo, Gianpiero, Libertini, Michela, Maconi, Antonio, Moss, Charlotte, Russell, Beth, Harbeck, Nadia, Vincenzi, Bruno, Bertulli, Rossella, Ottaviani, Diego, Liñan, Raquel, Marrari, Andrea, Carmona García, M. Carmen, Chopra, Neha, Tondini, Carlo Alberto, Mirallas, Oriol, Tovazzi, Valeria, Fotia, Vittoria, Cruz, Claudia Andrea, Saoudi González, Nadia, Felip, Eudald, Roqué, Ariadna, Lee, Alvin J. X., Newsom-Davis, Tom, García Illescas, David, Reyes, Roxana, Wong, Yien Ning Sophia, Ferrante, Daniela, Scotti, Lorenza, Marco Hernández, Javier, Ruiz Camps, Isabel, Patriarca, Andrea, Rimassa, Lorenza, Chiudinelli, Lorenzo, Franchi, Michela, Santoro, Armando, Prat Aparicio, Aleix, Gennari, Alessandra, Van Hemelrijck, Mieke, Tabernero Caturla, Josep, Diamantis, Nikolaos, Pinato, David J., OnCovid study group

المساهمون: Dettorre, G. M., Dolly, S., Loizidou, A., Chester, J., Jackson, A., Mukherjee, U., Zambelli, A., Aguilar-Company, J., Bower, M., Sng, C. C. T., Salazar, R., Bertuzzi, A., Brunet, J., Mesia, R., Sita-Lumsden, A., Segui, E., Biello, F., Generali, D., Grisanti, S., Seeva, P., Rizzo, G., Libertini, M., Maconi, A., Moss, C., Russell, B., Harbeck, N., Vincenzi, B., Bertulli, R., Ottaviani, D., Linan, R., Marrari, A., Carmen Carmona-Garcia, M., Chopra, N., Tondini, C. A., Mirallas, O., Tovazzi, V., Fotia, V., Cruz, C. A., Saoudi-Gonzalez, N., Felip, E., Roque, A., Lee, A. J. X., Newsom-Davis, T., Garcia-Illescas, D., Reyes, R., Wong, Y. N. S., Ferrante, D., Scotti, L., Marco-Hernandez, J., Ruiz-Camps, I., Patriarca, A., Rimassa, L., Chiudinelli, L., Franchi, M., Santoro, A., Prat, A., Gennari, A., Van Hemelrijck, M., Tabernero, J., Diamantis, N., Pinato, D. J., Wellcome Trust, Institut Català de la Salut, [Dettorre GM] Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. [Dolly S] Medical Oncology, Guy’s and St Thomas’ NHS Foundation Trust (GSTT), London, UK. [Loizidou A] Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. [Chester J] Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK. Medical Oncology, Velindre Cancer Centre, Cardiff, UK. [Jackson A] Clinical Trials, Velindre Cancer Centre, Cardiff, UK. [Mukherjee U] Medical Oncology, Barts Health NHS Trust, London, UK. [Aguilar-Company J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Mirallas O, Saoudi-Gonzalez N, García-Illescas D] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ruiz-Camps I] Servei de Malalties Infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Scientia

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Comorbidity, Systemic inflammation, Otros calificadores::Otros calificadores::/complicaciones [Otros calificadores], COVID-19 Testing, 0302 clinical medicine, Neoplasms, Immunotherapy Biomarkers, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], 80 and over, Immunology and Allergy, Medicine, Hypoalbuminemia, Young adult, Càncer, Multivariate Analysi, RC254-282, COVID-19 (Malaltia) - Complicacions, Cancer, Aged, 80 and over, OnCovid study group, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], Middle Aged, Prognosis, Inflamació, Systemic Inflammatory Response Syndrome, 030220 oncology & carcinogenesis, Cohort, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation::Systemic Inflammatory Response Syndrome [DISEASES], Molecular Medicine, Female, medicine.symptom, Life Sciences & Biomedicine, Human, Adult, medicine.medical_specialty, Prognosi, Càncer - Epidemiologia, Immunology, neoplasias [ENFERMEDADES], inflammation mediator, Young Adult, 03 medical and health sciences, Internal medicine, Humans, afecciones patológicas, signos y síntomas::procesos patológicos::inflamación::síndrome de respuesta inflamatoria sistémica [ENFERMEDADES], Aged, Pharmacology, Science & Technology, business.industry, SARS-CoV-2, COVID-19, medicine.disease, inflammation, inflammation mediators, Blood Cell Count, Multivariate Analysis, Neoplasms [DISEASES], Systemic inflammatory response syndrome, 030104 developmental biology, Neoplasm, Lymphocytopenia, business, Other subheadings::Other subheadings::/complications [Other subheadings]

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b479d72020cc81746269413907119b
http://hdl.handle.net/2445/176045

المؤلفون: Winkler WL; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA. Electronic address: winstonwinkler@wustl.edu., George IA; John T. Milliken Department of Internal Medicine, Division of Infectious Disease, St. Louis, USA., Gandra S; John T. Milliken Department of Internal Medicine, Division of Infectious Disease, St. Louis, USA., Baker JC; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA., Tomasian A; Department of Radiology, Section of Musculoskeletal Radiology, University of Southern California, Los Angeles, USA., Northrup B; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA., Velde TLV; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA., Hillen TJ; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA., Luo C; Division of Public Health Sciences, Washington University School of Medicine in St. Louis, St. Louis, USA., Imaoka R; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA., Dettorre GM; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA., Jennings JW; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, St. Louis, USA.

المصدر: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Jul; Vol. 144, pp. 107027. Date of Electronic Publication: 2024 Apr 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Osteomyelitis*/diagnosis , Osteomyelitis*/microbiology , Osteomyelitis*/pathology , Osteomyelitis*/drug therapy , Image-Guided Biopsy*/methods, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Biopsy, Large-Core Needle/methods ; Aged ; Adult ; Aged, 80 and over ; Spine/pathology ; Spine/diagnostic imaging ; Spine/microbiology ; Spinal Diseases/diagnosis ; Spinal Diseases/microbiology ; Spinal Diseases/pathology ; Spinal Diseases/drug therapy

المؤلفون: Winkler WL; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO, 63110, USA. winstonwinkler@wustl.edu., Baker JC; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO, 63110, USA., Tomasian A; Department of Radiology, Section of Musculoskeletal Radiology, University of Southern California, 1441 Eastlake Ave, Los Angeles, CA, 90089, USA., Vander Velde TL; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO, 63110, USA., Hillen TJ; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO, 63110, USA., Luo C; Division of Public Health Sciences, Washington University School of Medicine in St. Louis, 660 S Euclid Ave, St. Louis, MO, 63110, USA., Imaoka R; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO, 63110, USA., Dettorre GM; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO, 63110, USA., Jennings JW; Department of Radiology, Section of Musculoskeletal Radiology, Mallinckrodt Institute of Radiology, 510 S Kingshighway Blvd, St. Louis, MO, 63110, USA.

المصدر: European radiology [Eur Radiol] 2024 Feb 22. Date of Electronic Publication: 2024 Feb 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9114774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1084 (Electronic) Linking ISSN: 09387994 NLM ISO Abbreviation: Eur Radiol Subsets: MEDLINE

المؤلفون: Mostaghim A; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA., Minkove S; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, USA., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Ruiz-Camps I; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Eremiev-Eremiev S; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Dettorre GM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, USA., Fox L; Department of Hematology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Carmona-García M; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lambertini M; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Pria AD; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Rossi M; Oncology Unit, Azienda Ospedaliera 'SS Antonio e Biagio e Cesare Arrigo', Alessandria, Italy., Plaja A; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology-Badalona, Spain., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Barcelona, Spain., Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Michalarea V; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, Milan, Italy., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., Lee AJ; Cancer Division, University College London Hospital, London, UK., Murphy C; Cancer Division, University College London Hospital, London, UK., Belessiotis K; Cancer Division, University College London Hospital, London, UK., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Stoclin A; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain., Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Ospedale Maggiore della Carità Hospital, Novara, Italy., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Ospedale Maggiore della Carità Hospital, Novara, Italy., D'Avanzo F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Athale J; Critical Care Medicine, Mayo Clinic Arizona, Phoenix, USA., Eichacker P; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, USA., Pinato DJ; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK., Torabi-Parizi P; Critical Care Medicine Department, Clinical Center and National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892., Cortellini A; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Roma, Italy. Electronic address: a.cortellini@imperial.ac.uk.

مؤلفون مشاركون: OnCovid study group

المصدر: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Feb; Vol. 139, pp. 13-20. Date of Electronic Publication: 2023 Nov 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/complications , Neoplasms*/complications , Neoplasms*/drug therapy, Humans ; Male ; COVID-19 Testing ; Immune Checkpoint Inhibitors/therapeutic use ; Hospitalization ; Registries ; Retrospective Studies

المؤلفون: Vincenzi B; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, Du Cane Road, London, UK., Mazzocca A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Orlando S; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Romandini D; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Ruiz-Camps I; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Valverde Morales C; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain., Eremiev-Eremiev S; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Bertulli R; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Provenzano S; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Italy., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Spain., Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Vasiliki M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Jackson A; Velindre Cancer Centre, Cardiff, UK., Grosso F; Mesothelioma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Lee AJX; Cancer Division, University College London Hospital, London, UK., Murphy C; Cancer Division, University College London Hospital, London, UK., Belessiotis K; Cancer Division, University College London Hospital, London, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Ospedale Maggiore della Carità Hospital, Novara, Italy., Dettorre GM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy., Tucci M; Section of Medical Oncology, Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', Bari, Italy.; IRCCS, Istituto Tumori Giovanni Paolo II, Bari, Italy., Fulgenzi CAM; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Napolitano A; The Royal Marsden NHS Foundation Trust, London, UK., Pinato DJ; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Jan 18; Vol. 16, pp. 17588359231225028. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

المؤلفون: Rowland L; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Smart B; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Brown A; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Dettorre GM; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Gocho Y; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Hunt J; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Yang W; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Yoshimura S; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Reyes N; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Du G; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., John A; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Maxwell D; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Stock W; Hematopoiesis and Hematological Malignancies Program, University of Chicago, Chicago, IL, USA., Kornblau S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Relling MV; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Inaba H; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Pui CH; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Bourquin JP; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland., Karol SE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Evans WE; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Yang JJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Crews KR; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.

المصدر: Bio-protocol [Bio Protoc] 2023 Aug 05; Vol. 13 (15), pp. e4731. Date of Electronic Publication: 2023 Aug 05 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Bio-protocol LLC Country of Publication: United States NLM ID: 101635102 Publication Model: eCollection Cited Medium: Internet ISSN: 2331-8325 (Electronic) Linking ISSN: 23318325 NLM ISO Abbreviation: Bio Protoc Subsets: PubMed not MEDLINE

المؤلفون: Cortellini A; Department of Surgery & Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK alessiocortellini@gmail.com.; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128, Roma, Italy., Dettorre GM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Dafni U; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Disease, Vall d'Hebron University Hospital, Barcelona, Spain., Castelo-Branco L; Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland.; NOVA National School of Publich Health, NOVA University, Lisbon, Portugal., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy.; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Gennatas S; Medical Oncology Department, The Royal Marsden Hospital and NHS Foundation Trust, London, UK., Angelis V; Medical Oncology Department, The Royal Marsden Hospital and NHS Foundation Trust, London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Rogado J; Medical Oncology Department, Hospital Universitario Infanta Leonor, Madrid, Spain., Pedrazzoli P; Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., Viñal D; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain., Prat A; Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Rossi M; Oncology Department, ASO 'SS Antonio Biagio e Cesare Arrigo', Alessandria, Italy., Berardi R; Medical Oncology, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona, Italy., Alonso-Gordoa T; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy., Dimopoulou G; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece., Queirolo P; Melanoma Sarcoma and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy., Pradervand S; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Arnold D; Oncology, Haematology, Palliative Care Department, Asklepios Klinik Altona e Asklepios Kliniken, Hamburg, Germany., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Barcelona, Spain., Tucci M; Section of Medical Oncology, Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', Bari, Italy.; IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy., Harrington KJ; Division of Radiotherapy and Imaging, The Royal Marsden Hospital and The Institute of Cancer Research NIHR Biomedical Research Centre, London, UK., Mazzoni F; Medical Oncology, Careggi University Hospital, Florence, Italy., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Tsourti Z; Frontier Science Foundation-Hellas, Athens, Greece., Michielin O; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, 114 rue Edouard Vaillant, Villejuif, France., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Vincenzi B; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128, Roma, Italy., Tonini G; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200 - 00128, Roma, Italy., Patriarca A; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore della Carità, Novara, Italy., Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore della Carità, Novara, Italy., Krengli M; Division of Radiotherapy, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore Della Carita, Novara, Italy., Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain., Pentheroudakis G; Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore della Carità, Novara, Italy., Peters S; Scientific and Medical Division, ESMO (European Society for Medical Oncology), Lugano, Switzerland.; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., Romano E; Center for Cancer Immunotherapy, Department of Oncology, PSL Research University, Institut Curie, Paris, France., Pinato DJ; Department of Surgery & Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore della Carità, Novara, Italy.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Nov; Vol. 10 (11).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Neoplasms*/drug therapy , Neoplasms*/epidemiology, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; COVID-19 Testing ; SARS-CoV-2 ; Medical Oncology ; Registries

المؤلفون: Soosaipillai G; Cancer Division, University College London Hospitals, London, UK., Wu A; Cancer Division, University College London Hospitals, London, UK., Dettorre GM; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Chester J; Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK., Moss C; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, UK., Sng CC; Cancer Division, University College London Hospitals, London, UK., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC. Hospitalet de Llobregat, Spain., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Jones E; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Mesia R; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Jackson A; Clinical Trials, Velindre Cancer Centre, Cardiff, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Ottaviani D; Cancer Division, University College London Hospitals, London, UK., Carbó A; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Benafif S; Cancer Division, University College London Hospitals, London, UK., Würstlein R; Department of Gynaecology and Obstetrics, Breast Centre and Gynaecological Cancer Centre and CCC Munich, University Hospital Munich, Munich, Germany., Carmona C; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Chopra N; Cancer Division, University College London Hospitals, London, UK., Cruz CA; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Swallow J; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Saoudi N; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Felip E; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Galazi M; Cancer Division, University College London Hospitals, London, UK., Garcia-Fructuoso I; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lee AJX; Cancer Division, University College London Hospitals, London, UK., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, UK., Wong YNS; Cancer Division, University College London Hospitals, London, UK., Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Spain., Maluquer C; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Spain., Ruiz-Camps I; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Cabirta A; Department of Haematology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy., Ferrante D; Department of Translational Medicine, Unit of Cancer Epidemiology, CPO-Piemonte, University of Eastern Piedmont, Novara, Italy., Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Russell B; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Dolly S; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Hulbert-Williams NJ; Professor of Behavioural Medicine, Centre for Contextual Behavioural Science, School of Psychology, University of Chester, Chritchley Building, Parkgate Road, Chester, Cheshire, CH1 4BJ, UK., Pinato DJ; Department of Surgery and Cancer, Clinical Senior Lecturer and Consultant Medical Oncologist, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.

المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 Sep 02; Vol. 13, pp. 17588359211042224. Date of Electronic Publication: 2021 Sep 02 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE